Cardinal Health Inc (CAH)
Industry Medical Distribution
This stock can be held in an Investment ISA and an Investment Account
Sell
$231.14
Buy
$245.99
$-1.39 (-0.58%)
Prices updated at 09 Oct 2026, 23:12 EDT
| Prices minimum 15 mins delay
Prices in USD
Cardinal Health is one of three leading pharmaceutical wholesalers in the US, engaged in sourcing and distributing of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks ...
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
- Key stats
- Price
- Fair value
- Dividends
- News
- Financials
- Valuation
- Profile
Sector
Healthcare
Industry
Medical Distribution
Chairman
Ms. Patricia A. Hemingway Hall
CEO
Mr. Jason M. Hollar
Most recent earnings
30 Jun 2026
Fiscal year end
30 Jun 2026
Employees
63,900
Head office
7000 Cardinal Place
Dublin
United States
43017
Key personnel
Owner name | Salary |
|---|---|
Ms. Mary C. Scherer Senior Vice President and Chief Accounting Officer | - |
Mr. David C. Evans Independent Director | 0.15m |
Mr. Robert W. Musslewhite Independent Director | 0.12m |
Ms. Sheri H. Edison Independent Director | 0.15m |
Mr. Sudhakar Ramakrishna Independent Director | 0.12m |
Ms. Patricia A. Hemingway Hall Chairman of the Board | 0.16m |
Mr. Akhil Johri Independent Director | 0.13m |
Ms. Nancy Killefer Independent Director | 0.15m |
Mr. Robert W. Azelby Independent Director | 0.12m |
Mr. Jason M. Hollar Chief Executive Officer and Director | 1.50m |
Mr. Aaron E. Alt Chief Financial Officer | 0.90m |
Ms. Christine A. Mundkur Independent Director | 0.12m |
Ms. Jessica L. Mayer Chief Legal Officer and Chief Compliance Officer | 0.74m |
Mr. Stephen M. Mason Chief Executive Officer, GMPD Segment | 0.76m |
Ms. Michelle M. Brennan Independent Director | 0.14m |
Ms. Michelle D. Greene Chief Information Officer and Executive Vice President, Customer Support Services | - |
Ms. Deborah L. Weitzman Chief Executive Officer, Pharmaceutical and Specialty Solutions segment | 0.77m |
Ms. Valerie Christine Pitteroff Chief Human Resources Officer | - |
Top 5 shareholders
Owner name | No. of shares |
|---|---|
| BlackRock Inc | 28,494,855 |
| Vanguard Group Inc | 20,408,097 |
| Vanguard Capital Management, LLC | 15,288,709 |
| Vanguard Portfolio Management, LLC | 13,732,309 |
| State Street Corp | 12,074,518 |
Director dealings
Date | Action |
|---|---|
| 01 Dec 2025 | - |
| 01 Dec 2025 | - |
| 01 Dec 2025 | - |
| 01 Dec 2025 | - |
| 01 Dec 2025 | - |
| 05 Nov 2025 | - |
| 05 Nov 2025 | - |
| 05 Nov 2025 | - |
| 05 Nov 2025 | - |
| 05 Nov 2025 | - |
| 05 Nov 2025 | - |
| 05 Nov 2025 | - |
| 05 Nov 2025 | - |
| 05 Nov 2025 | - |
| 05 Nov 2025 | - |
| 20 Aug 2025 | - |
| 20 Aug 2025 | - |
| 20 Aug 2025 | - |
| 19 Aug 2025 | - |
| 19 Aug 2025 | - |
Please note that past performance is not a reliable indicator of future returns.